Stay updated with breaking news from Anna volerman. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
E-Mail Investigators at the University of Chicago Medicine have found that women are less likely to be represented as chairs and reviewers on study sections for the National Institutes of Health (NIH), based on data from one review cycle in 2019. The results, published on Feb. 15 in JAMA Network Open, have implications for the distribution of federal scientific funding. The NIH is the top source of federal funding for biomedical research in the U.S., providing critical support and guidance on the nation s research programs. The study sought to understand the gender distribution on NIH study sections, where scientific experts meet several times per year to discuss grant applications and determine what research will receive NIH funding. ....
Clinical trials of new treatments for COVID-19 often do not include vulnerable populations Studies examining the effectiveness of treatments for COVID-19 often do not include the very populations hardest hit by the disease, according to a new review by University of Chicago Medicine researchers. The findings, based on an analysis of all US COVID-19 treatment trials registered on ClinicalTrials.gov, were published Jan. 27 in the Journal of General Internal Medicine. This study highlights the blind spot in how clinical trials are done in the United States. Researchers, hospitals and pharmaceutical companies need to think hard about their commitment to improving the health of all people. ....
E-Mail Studies examining the effectiveness of treatments for COVID-19 often do not include the very populations hardest hit by the disease, according to a new review by University of Chicago Medicine researchers. The findings, based on an analysis of all US COVID-19 treatment trials registered on ClinicalTrials.gov, were published Jan. 27 in the Journal of General Internal Medicine. This study highlights the blind spot in how clinical trials are done in the United States, said senior author Neda Laiteerapong, MD, MS, a general internist and associate director of the Center for Chronic Disease Research and Policy at the University of Chicago. Researchers, hospitals and pharmaceutical companies need to think hard about their commitment to improving the health of all people. ....